Wells Fargo & Company Cin Cor Pharma, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$19.9 - $38.94 $2,407 - $4,711
-121 Reduced 72.46%
46 $2,000
Q2 2022

Aug 12, 2022
SELL
$13.67 - $25.74 $32,315 - $60,849
-2,364 Reduced 93.4%
167 $3,000
Q1 2022

May 16, 2022
BUY
$14.13 - $28.49 $35,763 - $72,108
2,531 New
2,531 $44,000

Others Institutions Holding CINC

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About CinCor Pharma, Inc.

CINC Quotes by TradingView
  • Ticker CINC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,764,300
  • Description
  • CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. It is involved in developing CIN-107, which is in Phase II clinical trial for the treatment of hypertension, primary aldosteronism, and other cardio-renal diseases, as well as in Phase I clinical trial...
More about CINC
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email